TEGOPEN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tegopen, and when can generic versions of Tegopen launch?
Tegopen is a drug marketed by Apothecon and is included in two NDAs.
The generic ingredient in TEGOPEN is cloxacillin sodium. There are twenty-three drug master file entries for this compound. Additional details are available on the cloxacillin sodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TEGOPEN?
- What are the global sales for TEGOPEN?
- What is Average Wholesale Price for TEGOPEN?
Summary for TEGOPEN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 34 |
| Patent Applications: | 4,252 |
| DailyMed Link: | TEGOPEN at DailyMed |
US Patents and Regulatory Information for TEGOPEN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apothecon | TEGOPEN | cloxacillin sodium | FOR SOLUTION;ORAL | 061453-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Apothecon | TEGOPEN | cloxacillin sodium | FOR SOLUTION;ORAL | 050192-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
